这是描述信息
Location:
Homepage
/
/
New situation, new challenge-2020 National Tuberculosis Prevention and Control Program Anti-tuberculosis Drug Management Seminar was successfully held in Nanchong

New situation, new challenge-2020 National Tuberculosis Prevention and Control Program Anti-tuberculosis Drug Management Seminar was successfully held in Nanchong

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2020-10-17
  • Views:0

(Summary description)In order to further standardize and promote the management of anti-tuberculosis drugs nationwide, on October 13th, the China Centers for Disease Control and Prevention organized the 2020 National Tuberculosis Drug Management Seminar in Nanchong City

New situation, new challenge-2020 National Tuberculosis Prevention and Control Program Anti-tuberculosis Drug Management Seminar was successfully held in Nanchong

(Summary description)In order to further standardize and promote the management of anti-tuberculosis drugs nationwide, on October 13th, the China Centers for Disease Control and Prevention organized the 2020 National Tuberculosis Drug Management Seminar in Nanchong City

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2020-10-17
  • Views:0
Information

  In order to further standardize and promote the management of anti-tuberculosis drugs nationwide, on October 13th, the China Centers for Disease Control and Prevention organized the 2020 National Tuberculosis Drug Management Seminar in Nanchong City, Sichuan Province, from 31 provinces (autonomous regions) across the country. More than 50 anti-tuberculosis drug managers and relevant responsible comrades from the Center for Disease Control and Prevention (TBC) of the municipality directly under the Central Government attended the meeting. 

  

Figure 1: The opening ceremony of the 2020 National Anti-tuberculosis Drug Management Symposium

  Zhao Yanlin, Director of the Control Center of China CDC, Xiao Yuming, Deputy Director of the Major Infectious Diseases Division of the Sichuan Provincial Health Commission, Zhang Linglin, Deputy Director of the Sichuan CDC, Chen Chuang, Director of the Tuberculosis Prevention and Control Institute of the Sichuan CDC, China CDC Leaders and experts, including Zhou Lin, director of the Patient Care Department of the Control Center, Zhu Shengguo, director of the Nanchong Municipal Health Commission, and Wang Xin, director of the Nanchong CDC, attended the opening ceremony. The opening ceremony was presided over by Director Zhou Lin. At the opening ceremony, Xiao Yuming, deputy director of the Major Infectious Diseases Department of the Sichuan Provincial Health Commission, and Zhu Shengguo, director of the Nanchong Municipal Health Commission, respectively delivered welcome speeches and introduced the status and progress of tuberculosis prevention and control in Sichuan Province and Nanchong City. In his speech, Director Zhao Yanlin of the Control Center of China CDC emphasized the important role of standardized management of anti-tuberculosis drugs in tuberculosis prevention and treatment planning. He pointed out the current bottlenecks in the varieties, prices, and procurement of anti-tuberculosis drugs in China. Under the current situation, actively think about drug management issues and provide new ideas for the country to formulate drug security related policies in the future. Director Zhao also put forward requirements for the promotion of anti-tuberculosis drug management to the provinces, and do a good job in the prevention and control of TB under the normal prevention and control of the new crown epidemic Do a good job in the final evaluation of the "Thirteenth Five-Year Plan" tuberculosis prevention and control plan, and plan ahead of schedule the "14th Five-Year Plan" national tuberculosis control plan.

Figure 2: Director Zhou Lin introduced the current status and progress of anti-tuberculosis drug management in my country

  Director Zhou Lin conducted a systematic analysis and elaboration on my country’s tuberculosis epidemic, types of anti-tuberculosis drugs, procurement requirements, standardized treatment plans for tuberculosis, and patient usage and unit coverage of anti-tuberculosis fixed-dose combination preparations, and explained the next step in each province. Specific measures have been proposed to standardize drug management.
  The meeting also invited Director Xu Caihong of the Comprehensive Business Department of the National Control Center to give lectures. Director Xu gave a detailed explanation of my country’s tuberculosis prevention and control strategies, tuberculosis prevention and control work requirements, and assessment plans in a point-to-face manner, so that everyone can understand how to analyze and decompose each item. The influencing links of each work indicator, how to carry out the work more meticulously and concretely, how to report the information more accurately, etc.
  The seminar also invited representatives from the eight provinces of Sichuan, Shaanxi, Chongqing, Xinjiang, Hainan, Hubei, Hunan, and Jilin to exchange experiences on the bidding, procurement, storage, distribution, and management of anti-tuberculosis drugs in their provinces, and gave the representatives from the participating provinces Important enlightenment and reference have been unanimously recognized by everyone.
 
 
Figure 3: Provincial representatives share experience in anti-tuberculosis drug management
 
  Through this seminar, it will play a major role in further standardizing the management of anti-tuberculosis drugs in various provinces and improving the management of anti-tuberculosis drugs. The seminar also brought new vision, new ideas and new inspiration to everyone in the prevention and control of tuberculosis.
  During the meeting, General Manager Lu Wenhua of the Government Procurement Affairs Department led the company's political procurement team to communicate with relevant leaders and drug managers of the country and provinces on the management of anti-tuberculosis drugs to further enhance the understanding of FDC. Strengthening the treatment and management of FDC for pulmonary tuberculosis patients is one of the important measures to standardize the treatment of pulmonary tuberculosis patients, improve the compliance of pulmonary tuberculosis patients, and control the occurrence of drug-resistant tuberculosis.

Scan the QR code to read on your phone

Copyright hongqipharma.com All rights reserved     Powered by:300.cn Shenyang    辽icp备12005917号    (辽)-非经营性-2018-0012 

Add:Shenyang Hunnan New District envelope 6th Street    Tel:024-23786268-8012  Fax:024-23786263